Drug intelligence / Profile preview

Asmagon

Development stage: Unknown
Lead developer: AVN Ayurveda
Administration: Oral

Overview

Asmagon is a proprietary Ayurvedic polyherbal formulation developed by AVN Ayurveda Formulations for the management of respiratory disorders. It is an adaptation of the classical Ayurvedic medicine Agastya Rasayanam and contains concentrated aqueous extracts of herbs such as Dashamoola, Pippali (Piper longum), Bhringaraja (Eclipta alba), and Haritaki (Terminalia chebula). The formulation is indicated for bronchial asthma, chronic cough, and as an adjuvant in tuberculosis and primary complex. It functions as a bronchodilator, anti-inflammatory, mucolytic, and anti-tussive agent, while also modulating the immune response to allergens and building resistance against respiratory pathogens.

Brand names: Asmagon
Other names: Asmagon-AVN Ayurveda Formulations-herbal formulation

Beyond the preview

Go deeper on Asmagon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asmagon.

Explore the full profile